Search

We assessed clinical intake paperwork (N = 128) from three similar, mid-sized Midwestern counties for cultural variable inclusion and response formats (i.e., checkbox, open-ended) via systematic content analysis. We found no patterns across intakes or geographic area in terms of which cultural variables counselors included on their intake paperwork, though we found consistency in terms of response type. To date, few researchers have examined counselor intake paperwork, specifically cultural variable inclusion, and theoretical recommendations are inconsistent. We suggest that asking about client cultural identities on intake paperwork is a vital first step in the counseling process, demonstrating openness, warmth, and unconditional positive regard as a foundation for the working alliance. We present pertinent literature and research findings and offer recommendations for counseling professionals to strengthen cultural identity inclusion in their intake paperwork., According to the American Counseling Association (ACA, 2014) Code of Ethics, assessment is 'the process of collecting in-depth information about a person in order to develop a comprehensive plan that [...]

The authors track the progression of an easily preventable skin infection of a high school athlete that occurred due to the lack of a cleanliness protocol in a high school gym. The extensive and expensive progress of the infection resulted in a major near-death event for the teen. Guidelines for school athletic programs are included. The ethical principle or justice supports nursing and public attention to prevention rather than tertiary care., Ryan, a 16-year-old male, is on the Junior Varsity Wrestling Team in a central California high school. Ryan is very active in multiple sports, school events, academics, and social events. [...]

Background. The antitumor activity of the chemical conjugate and recombinant forms of the mitotoxin basic fibroblast growth factor (bFGF) saporin (SAP) and the bFGF receptor-directed immunotoxin 11A8-SAP against human ovarian teratocarcinoma PA-1 was examined in athymic nude mice. Alternative administration schedules to prolong therapeutic efficacy were explored. Methods. Intravenous dosing (0.01-125 [micro]g/kg) of chemical conjugate and recombinant bFGF-SAP or 11A8-SAP beginning 5 days after subcutaneous implantation of PA-1 cells was administered by i) weekly injection for 4 weeks, ii) continuous infusion for one week, or iii) daily injection five times a week for 4 weeks. Results. Weekly injections (31.25 [micro]g/kg) of chemical conjugate bFGF-SAP or 11A8-SAP, the latter of which is 25% the molarity of the former, resulted in mean tumor volumes that were, respectively, 35% or 52% of controls (day 30) and 52% or 76% of controls (day 60). Chemical conjugate or recombinant bFGF-SAP administered weekly resulted in mean tumor volumes that were respectively, 51% or 77% (0.5 [micro]g/kg) and 42% or 31% (50 [micro]g/kg) of controls (day 30). A mean tumor volume of 35% of controls (day 30) and of 49% of controls (day 60) were observed in animals treated by constant infusion of chemical conjugate bFGF-SAP (125 [micro]g/kg, total dose). Alternatively, tumors of animals receiving daily injections (125 [micro]g/kg, total dose) exhibited a mean volume of 21% of controls (day 30) and prolonged growth inhibition as demonstrated by a mean tumor volume of 22% of controls (day 60). Conclusions. These studies suggest a therapeutic potential for bFGF-receptor-directed saporin toxins in the treatment of ovarian teratocarcinoma and the importance of frequency of administration in achieving optimal tumor responses Cancer 1995; 76:79-85. Key words: ovarian teratocarcinoma, basic fibroblast growth factor-receptor, saporin, mitotoxin, immunotoxin.

In 30 to 45 percent of the patients with insulin-dependent diabetes, nephropathy (disease of the kidney) develops. High blood pressure usually develops from the nephropathy, which itself quickens the progression to renal failure. Complications involving the kidneys are the major cause of death occurring in diabetes. The earliest sign of nephropathy is an increased rate of excretion of the protein albumin in the urine. Angiotensin converting enzyme inhibitors are effective in reducing the level of albumin excreted by the kidneys and lowering blood pressure. The angiotensin converting enzyme inhibitor captopril was tested for its ability to lower the excretion rate of albumin in 12 adolescents with diabetes and microalbuminuria, who had not developed high blood pressure. The average age of the youths was 14 years and they had had diabetes for an average of five years. The rate of excretion of albumin decreased significantly during treatment with captopril compared with patients in a control group, who were treated with a placebo. Blood pressure decreased slightly in patients treated with captopril. After three months of treatment, there were no complications in the filtration rates of the glomerulus of the kidney nor in the blood flow through the kidneys. Only one of the patients in this study developed diarrhea as a side effect to the captopril treatment. Longer trials are necessary to see if treatment with the angiotensin converting enzyme inhibitor captopril delays or prevents nephropathies in adolescents with diabetes. (Consumer Summary produced by Reliance Medical Information, Inc.)

A study is conducted to determine whether the rate of falls and associated serious injuries in a hospital aged care setting can be reduced using a multistrategy prevention approach. The approach produced a significant reduction in the number of falls and a marked reduction in serious fall-related injuries.

Evaluates the Pilates whole body workout machine. How the machine was developed; Health benefits of the machine to skiers; Premise of using the machine.

Discusses several health and fitness issues. Factors that triggered exercise-induced asthma (EIA); Information on the video `Cross Training with Yoga,' from Yoga for Athletes; Use of lip balms for skiers.

Focuses on news related to the health and fitness of skiers, current as of March 1998. Includes US Food and Drug Administration's approval of Genzyme Tissue Repair's Carticel treatment for skiers with bad knees; Success of the energy drink called Red Bull.